CMEA Capital (www.cmea.com) provides capital and counseling to entrepreneurs and investors in the life sciences, information technology, and energy & material sectors. Through its combination of solid scientific credentials and seasoned management expertise, CMEA identifies, funds, and manages new businesses based on the emerging, interdisciplinary science required to meet the challenges and opportunities of a rapidly changing global economy.

Pangaea Ventures (www.pangaeaventures.com) is a venture capital firm that invests in early-stage advanced materials, energy and environmental technology companies. It has offices in Vancouver and New Jersey and makes investments across the United States and Canada.

Managing two funds at this time, the Pangaea team provides effective support to its portfolio companies with its deep domain knowledge coupled with start-up, operational and transactional expertise

With close to $400M under management, WI Harper (www.wiharper.com) is one of the first U.S.-based venture capital firms to create a value-adding bridge between the United States and Greater China. For nearly a decade, WI Harper has been building companies internationally by facilitating the flow of capital, technology and management best practices across both sides of the Pacific. The Firm is focused on fueling companies at early expansion stage within Internet, wireless, digital media and life science / healthcare sectors. WI Harper's star portfolios include Focus Media (FMCN), DivX (DIVX), Beijing Xinwei, Bridge Pharmaceutical, Cardiva Medical, Commerce One, Celestry (purchased by Cadence), Intraware, iKang Healthcare, MJ Group, Panorama Stock, SirF (SIRF), 3G.CN, Maxthon and Verisilicon.

IDG Capital Partners (www.idgvc.com) is a China-focused investment firm with over US$2.5B capital under management. Our offices are located in Hong Kong, Beijing, Shanghai, Guangzhou, Shenzhen, Silicon Valley, and Boston. We primarily focus on leading companies in consumer products, franchise services, internet and wireless application, new media, education, healthcare, new energy, and advanced manufacturing sectors. We invest in all stages of the company lifecycle from early stage to pre-IPO. Our investments range from US$1M to US$100M.Since 1992, as one of the earliest foreign investment funds to enter the Chinese market, we have invested in over 200 diverse outstanding companies, such as Ctrip, Home Inns, Baidu, Soufun, Tencent, Kingdee, China Finance Online, Sohu, Wu-Mart, EVE NY, Andon, VANCL and Hanting. We have successfully exited from 50 investments through M&A or IPO in US, Hong Kong and China.